Expression of SIRT1 and DBC1 in Gastric Adenocarcinoma
1
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background: Sirtuin 1 (SIRT1) and deleted in breast cancer 1 (DBC1) are known as tumor suppressor or promoter genes. This may be due to their diverse functions and interaction with other proteins. Gastric adenocarcinoma is one of the most common malignancies, but little is known about its carcinogenesis. Therefore, we investigated the association of immunohistochemical expression of SIRT1, DBC1, p53, and β-catenin and their variable clinicopathological characteristics. Methods: We obtained samples from 452 patients who underwent gastrectomy. Tissue microarray blocks were constructed and immonohistochemical staining was performed. Results: Expression of DBC1 and SIRT1 was associated with lower histologic grade, intestinal type of Lauren classification, and lower pT (p<0.001) and pN stage (DBC1, p=0.002; SIRT1, p<0.001). Association between absence of lymphatic invasion, and SIRT1 (p=0.001) and DBC1 (p=0.004) was observed. Cytoplasmic β-catenin expression was associated with lower histologic grade, pT, pN, tumor-node-metastasis (TNM) stage, DBC1 (p<0.001), and SIRT1 (p=0.001). Expression of SIRT1 and DBC1 was not associated with p53 (p=0.063 and p=0.060). DBC1 was an independent good prognostic factor in multivariate analysis (p=0.012). Conclusions: SIRC1 and DBC1 can be considered to be good prognostic factors in gastric adenocarcinoma.
Abstract
Background: Sirtuin 1 (SIRT1) and deleted in breast cancer 1 (DBC1) are known as tumor suppressor or promoter genes. This may be due to their diverse functions and interaction with other proteins. Gastric adenocarcinoma is one of the most common malignancies, but little is known about its carcinogenesis. Therefore, we investigated the association of immunohistochemical expression of SIRT1, DBC1, p53, and β-catenin and their variable clinicopathological characteristics. Methods: We obtained samples from 452 patients who underwent gastrectomy. Tissue microarray blocks were constructed and immonohistochemical staining was performed. Results: Expression of DBC1 and SIRT1 was associated with lower histologic grade, intestinal type of Lauren classification, and lower pT (p<0.001) and pN stage (DBC1, p=0.002; SIRT1, p<0.001). Association between absence of lymphatic invasion, and SIRT1 (p=0.001) and DBC1 (p=0.004) was observed. Cytoplasmic β-catenin expression was associated with lower histologic grade, pT, pN, tumor-node-metastasis (TNM) stage, DBC1 (p<0.001), and SIRT1 (p=0.001). Expression of SIRT1 and DBC1 was not associated with p53 (p=0.063 and p=0.060). DBC1 was an independent good prognostic factor in multivariate analysis (p=0.012). Conclusions: SIRC1 and DBC1 can be considered to be good prognostic factors in gastric adenocarcinoma.
참고문헌 (30)
- Guarente L, "Calorie restriction: the SIR2 connection", Cell, 120, pp.473~482 (2005)
- Zhenkun Lou, "DBC1 is a negative regulator of SIRT1", NATURE, 451(7178), pp.583~10, NATURE PUBLISHING GROUP
- Firestein R, "The SIRT1 deacetylase suppresses intestinal tumorigenesis and colon cancer growth", PLoS One, 3, pp.2020~ (2008)
- Chen WY, "Tumor suppressor HIC1 directly regulates SIRT1 to modulate p53-dependent DNA-damage responses", Cell, 123, pp.437~448 (2005)
- Hida Y, "Strong expression of a longevity-related protein, SIRT1, in Bowen’s disease", Arch Dermatol Res, 299, pp.103~106 (2007)
- Kuzmichev A, "Composition and histone substrates of polycomb repressive group complexes change during cellular differentiation", Proc Natl Acad Sci U S A, 102, pp.1859~1864 (2005)
- Huffman DM, "SIRT1 is significantly elevated in mouse and human prostate cancer", Cancer Res, 67, pp.6612~6618 (2007)
- Lee H, "Expression of DBC1 and SIRT1 is associated with poor prognosis for breast carcinoma", Hum Pathol, 42, pp.204~213 (2011)
- Saunders LR, "Sirtuins: critical regulators at the crossroads between cancer and aging", Oncogene, 26, pp.5489~5504 (2007)
- Feng AN, "Expression of SIRT1 in gastric cardiac cancer and its clinicopathologic significance", Int J Surg Pathol, 19, pp.743~750 (2011)
- Cha EJ, "Expression of DBC1 and SIRT1 is associated with poor prognosis of gastric carcinoma", Clin Cancer Res, 15, pp.4453~4459 (2009)
- Czyzewska J, "The expression of E-cadherin-catenin complex in patients with advanced gastric cancer: role in formation of metastasis", Folia Histochem Cytobiol, 48, pp.37~45 (2010)
- Ciocca DR, "Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications", Cell Stress Chaperones, 10, pp.86~103 (2005)
- Hamaguchi M, "DBC2, a candidate for a tumor suppressor gene involved in breast cancer", Proc Natl Acad Sci U S A, 99, pp.13647~13652 (2002)
- Zhao W, "Negative regulation of the deacetylase SIRT1 by DBC1", Nature, 451, pp.587~590 (2008)
- Fu J, "Deleted in breast cancer 1, a novel androgen receptor (AR) coactivator that promotes AR DNA-binding activity", J Biol Chem, 284, pp.6832~6840 (2009)
- Trauernicht AM, "Modulation of estrogen receptor alpha protein level and survival function by DBC-1", Mol Endocrinol, 21, pp.1526~1536 (2007)
- 박세훈, "위암 항암치료의 최신지견", 대한내과학회지, 82(4), pp.417~426 (2012), 대한내과학회[DOI]
- Jang BG, "Molecular pathology of gastric carcinoma", Pathobiology, 78, pp.302~310 (2011)
- Edge SB, "AJCC cancer staging handbook: from the AJCC cancer staging manual. 7th ed" (2010), Springer
- Bosman FT, "WHO classification of tumours of the digestive system. 4th ed" (2010), IARC Press
- Vaziri H, "hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase", Cell, 107, pp.149~159 (2001)
- Luo J, "Negative control of p53 by Sir2alpha promotes cell survival under stress", Cell, 107, pp.137~148 (2001)
- Kyrylenko S, "Differential regulation of the Sir2 histone deacetylase gene family by inhibitors of class I and II histone deacetylases", Cell Mol Life Sci, 60, pp.1990~1997 (2003)
- Ford J, "Cancer-specific functions of SIRT1 enable human epithelial cancer cell growth and survival", Cancer Res, 65, pp.10457~10463 (2005)
- Kim JE, "Interactions between DBC1 and SIRT 1 are deregulated in breast cancer cells", Cell Cycle, 8, pp.3784~3785 (2009)
- Mullan PB, "The role of BRCA1 in transcriptional regulation and cell cycle control", Oncogene, 25, pp.5854~5863 (2006)
- 김현석, "Interplay among BRCA1, SIRT1, and Survivin during BRCA1-Associated Tumorigenesis", MOLECULAR CELL, 32(1), pp.11~20, CELL PRESS
- Yeung F, "Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase", EMBO J, 23, pp.2369~2380 (2004)
- Lin SJ, "Requirement of NAD and SIR2 for life-span extension by calorie restriction in Saccharomyces cerevisiae", Science, 289, pp.2126~2128 (2000)